The liver possesses the unique ability to regenerate within a short period of time, a feature
that has led to the development of innovative strategies in liver surgery and transplantation …

Colorectal carcinoma (CRC) is the third most common cancer, and approximately 35%-55%
of patients with CRC will develop hepatic metastases during the course of their disease …

Vascular disorders of the liver, although affecting less than 5/10,000 patients, collectively
account for a number of rare conditions that represent an important health problem …

An international panel of multidisciplinary experts convened to develop recommendations
for the management of patients with liver metastases from colorectal cancer (CRC). The aim …

Hepatic resection offers a chance of a cure in selected patients with colorectal liver
metastases (CLM). To achieve adequate patient selection and curative surgery,(i) precise …

Purpose The primary goal of this study was to evaluate whether pathologic response to
chemotherapy predicts patient survival after preoperative chemotherapy and resection of …

Background The safety of simultaneous resections of colorectal cancer and synchronous
liver metastases (SCRLM) is not established. This multi-institutional retrospective study …

The past 5 years have seen the clear recognition that the administration of chemotherapy to
patients with initially unresectable colorectal liver metastases can increase the number of …

Rubbia‐Brandt L, Lauwers GY, Wang H, Majno PE, Tanabe K, Zhu AX, Brezault C,
Soubrane O, Abdalla EK, Vauthey J‐N, Mentha G & Terris B (2010) Histopathology56, 430 …

BACKGROUND. The current study evaluated the effect of bevacizumab added to
fluoropyrimidine‐plus‐oxaliplatin (5FU/OX) chemotherapy for colorectal liver metastases …